Article Details

Conatus Pharmaceuticals (NASDAQ:CNAT) Upgraded to “Hold” at ValuEngine

Retrieved on: 2020-01-25 08:00:00

Tags for this article:

Click the tags to see associated articles and topics

Conatus Pharmaceuticals (NASDAQ:CNAT) Upgraded to “Hold” at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Acadian Asset Management</b> LLC lifted its stake in Conatus Pharmaceuticals Inc (NASDAQ:CNAT) by 90.7% in the second quarter, according to the ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up